FDA.reportPublic FDA data

sitagliptin phosphate 25 MG Oral Tablet

RxCUI
2709612
RxNorm name
sitagliptin phosphate 25 MG Oral Tablet
Display name
sitagliptin phosphate 25 MG Oral Tablet
Full name
sitagliptin phosphate 25 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JANUVIASITAGLIPTINA-S Medication Solutions4a758211-8af1-449b-9a10-f3d67d7ec8b62026-07-08Warnings, Adverse reactionsExact identifier
rxcui: 2709612
JANUVIASITAGLIPTINA-S Medication Solutions1b03c82f-b52e-4092-b9dc-f2c9b0d6ab402026-07-08Warnings, Adverse reactionsExact identifier
rxcui: 2709612
Sitagliptin PhosphateSITAGLIPTIN PHOSPHATESandoz Inccebc8388-c9db-4e27-8d6b-0d9bdc9d766d2026-05-10Warnings, Adverse reactionsExact identifier
rxcui: 2709612
SitagliptinSITAGLIPTINApotex Corp.983e9e14-e9bd-3136-e573-98b4dc67860b2026-04-14Warnings, Adverse reactionsExact identifier
rxcui: 2709612
SitagliptinSITAGLIPTINTeva Pharmaceuticals, Inc.5fa5aa67-455e-4ac6-864d-268a912864322025-12-01Warnings, Adverse reactionsExact identifier
rxcui: 2709612
JANUVIASITAGLIPTINMerck Sharp & Dohme LLCf85a48d0-0407-4c50-b0fa-7673a160bf012024-11-14Warnings, Adverse reactionsExact identifier
rxcui: 2709612

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f85a48d0-0407-4c50-b0fa-7673a160bf01sitagliptin phosphate 25 MG Oral TabletSCD71These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620241114
f85a48d0-0407-4c50-b0fa-7673a160bf01SITagliptin phosphate 25 MG Oral TabletPSN71These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620241114
1b03c82f-b52e-4092-b9dc-f2c9b0d6ab40sitagliptin phosphate 25 MG Oral TabletSCD7These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620230720
1b03c82f-b52e-4092-b9dc-f2c9b0d6ab40SITagliptin phosphate 25 MG Oral TabletPSN7These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620230720
cebc8388-c9db-4e27-8d6b-0d9bdc9d766dsitagliptin phosphate 25 MG Oral TabletSCD5These highlights do not include all the information needed to use SITAGLIPTIN TABLETS safely and effectively. See full prescribing information for SITAGLIPTIN TABLETS. SITAGLIPTIN tablets, for oral use Initial U.S. Approval: 200620260114
cebc8388-c9db-4e27-8d6b-0d9bdc9d766dSITagliptin phosphate 25 MG Oral TabletPSN5These highlights do not include all the information needed to use SITAGLIPTIN TABLETS safely and effectively. See full prescribing information for SITAGLIPTIN TABLETS. SITAGLIPTIN tablets, for oral use Initial U.S. Approval: 200620260114
4a758211-8af1-449b-9a10-f3d67d7ec8b6sitagliptin phosphate 25 MG Oral TabletSCD5These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620230616
4a758211-8af1-449b-9a10-f3d67d7ec8b6SITagliptin phosphate 25 MG Oral TabletPSN5These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620230616
92829830-b869-4ec8-b498-73f5b2e8e7beSITagliptin phosphate 25 MG Oral TabletPSN5These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620230616
92829830-b869-4ec8-b498-73f5b2e8e7besitagliptin phosphate 25 MG Oral TabletSCD5These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620230616
983e9e14-e9bd-3136-e573-98b4dc67860bSITagliptin phosphate 25 MG Oral TabletPSN2These highlights do not include all the information needed to use SITAGLIPTIN TABLETS safely and effectively. See full prescribing information for SITAGLIPTIN TABLETS . SITAGLIPTIN tablets, for oral use Initial U.S. Approval: 200620260414
983e9e14-e9bd-3136-e573-98b4dc67860bsitagliptin phosphate 25 MG Oral TabletSCD2These highlights do not include all the information needed to use SITAGLIPTIN TABLETS safely and effectively. See full prescribing information for SITAGLIPTIN TABLETS . SITAGLIPTIN tablets, for oral use Initial U.S. Approval: 200620260414